Hyperglycemia and Diabetes Mellitus Following Organ Transplantation.

Abstract:

:Hyperglycemia is common following organ transplantation, regardless of the pre-transplant diabetes status. Transient post-transplant hyperglycemia and/or new-onset diabetes after transplantation (NODAT) are common and are associated with increased morbidity and mortality. NODAT and type 2 diabetes share similar characteristics, but the pathophysiology may differ. Immunosuppressive agents and steroids play a key role in the development of NODAT. Glycemic control is challenging in this population due to fluctuating renal/end-organ function, immunosuppressive dosing, nutritional status, and drug-drug interactions. A proactive and multidisciplinary approach is essential, along with flexible protocols to adjust to patient status, type of organ transplanted, and corticosteroid regimens. Insulin is the preferred agent for hospitalized patients and during the early post-transplant period; optimal glycemic control (BG < 180 mg/dl with minimal hypoglycemia [<70 mg/dl]) is desired.

journal_name

Curr Diab Rep

journal_title

Current diabetes reports

authors

Galindo RJ,Wallia A

doi

10.1007/s11892-015-0707-1

subject

Has Abstract

pub_date

2016-02-01 00:00:00

pages

14

issue

2

eissn

1534-4827

issn

1539-0829

pii

10.1007/s11892-015-0707-1

journal_volume

16

pub_type

杂志文章,评审
  • Gut Immunity and Type 1 Diabetes: a Mélange of Microbes, Diet, and Host Interactions?

    abstract::Type 1 diabetes (T1D) is a complex autoimmune disease, and first stages of the disease typically develop early in life. Genetic as well as environmental factors are thought to contribute to the risk of developing autoimmunity against pancreatic beta cells. Several environmental factors, such as breastfeeding or early ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-016-0753-3

    authors: Endesfelder D,Engel M,Zu Castell W

    更新日期:2016-07-01 00:00:00

  • Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy.

    abstract:PURPOSE OF REVIEW:Gestational diabetes (GDM) is associated with adverse pregnancy and neonatal outcomes and increased maternal risk for subsequent type 2 diabetes. The best diagnostic strategy for GDM is debated and the role of oral antidiabetic medications (OAD) for treatment is unclear. In this paper, we review metho...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1147-0

    authors: Dickens LT,Thomas CC

    更新日期:2019-05-09 00:00:00

  • Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.

    abstract::Diabetes mellitus and obesity have become increasingly prevalent problems worldwide. Unfortunately, with traditionally prescribed glucose-lowering medications most individuals with diagnosed diabetes do not achieve and maintain adequate glycemic control over time; it may be even more challenging to lower blood glucose...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-007-0060-0

    authors: Green JB,Feinglos MN

    更新日期:2007-10-01 00:00:00

  • FTO and obesity: mechanisms of association.

    abstract::The Fat mass and obesity associated (FTO) gene is a newly identified genetic factor for obesity. However, the exact molecular mechanisms responsible for the effect of FTO on obesity remain largely unknown. Recent studies from genome-wide associated studies reveal that genetic variants in the FTO gene are associated no...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-014-0486-0

    authors: Zhao X,Yang Y,Sun BF,Zhao YL,Yang YG

    更新日期:2014-01-01 00:00:00

  • Euglycemic Ketoacidosis.

    abstract:PURPOSE OF REVIEW:Diabetic ketoacidosis is a life-threatening complication of diabetes characterized by hyperglycemia, acidosis, and ketosis. Ketoacidosis may occur with blood glucose level < 200 mg/dl (improperly defined as euglycemic ketoacidosis, euKA) and also in people without diabetes. The absence of marked hyper...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01307-x

    authors: Bonora BM,Avogaro A,Fadini GP

    更新日期:2020-05-19 00:00:00

  • The Evolving Role of the Cardiologist in the Management of Type 2 Diabetes.

    abstract:PURPOSE OF REVIEW:To evaluate the treatment of type 2 diabetes from a cardiologist's view. RECENT FINDINGS:A new era in the treatment of type 2 diabetes began for the cardiologist in 2015 with the publication of the EMPA-REG outcome trial finding a significant reduction in CV death with empagliflozin (oral sodium-gluc...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1114-1

    authors: Chilton RJ,Gallegos KM,Silva-Cardoso J,Oliveros R,Pham S

    更新日期:2018-11-08 00:00:00

  • Insulin sensitivity and premenstrual syndrome.

    abstract::Maintaining normal blood glucose levels is a constant challenge for women with diabetes. Anecdotal reports reveal that many women question if menstrual cycle phases may affect their blood glucose levels. However, results from studies investigating the effect of the menstrual cycle on insulin sensitivity in diabetic wo...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-004-0079-4

    authors: Trout KK,Teff KL

    更新日期:2004-08-01 00:00:00

  • Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults.

    abstract:PURPOSE OF REVIEW:Evidence-based treatments for prediabetes can prevent and delay the development of type 2 diabetes in adults. In this review, we propose a framework for population-based diabetes prevention that links screening and prevention activities across key stakeholders. We also discuss gaps in current practice...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1090-5

    authors: Bowen ME,Schmittdiel JA,Kullgren JT,Ackermann RT,O'Brien MJ

    更新日期:2018-09-19 00:00:00

  • Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad.

    abstract:PURPOSE OF REVIEW:The micro/macrovascular complications of diabetes cause considerable morbidity and premature mortality. The SGLT2 inhibitors are the first diabetes medications with significant benefits on microvascular disease (nephropathy) and macrovascular cardiovascular disease. In this review, we evaluate one of ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01359-z

    authors: Ekanayake P,Hupfeld C,Mudaliar S

    更新日期:2020-11-23 00:00:00

  • Pathogenesis and prevention of type 2 diabetes: parental determinants, breastfeeding, and early childhood nutrition.

    abstract::Among the factors predisposing to type 2 diabetes in children, adolescents, and young adults, the health and behavior of both the mother and father are critical. Prevention and treatment of parental nutritional disorders (including obesity and malnutrition), promotion of breastfeeding, and avoidance of overfeeding of ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-011-0246-3

    authors: Bartz S,Freemark M

    更新日期:2012-02-01 00:00:00

  • Genetic and Environmental Interaction in Type 1 Diabetes: a Relationship Between Genetic Risk Alleles and Molecular Traits of Enterovirus Infection?

    abstract:PURPOSE OF REVIEW:We provide an overview of the current knowledge regarding the natural history of human type 1 diabetes (T1D) and the documented associations between virus infections (in particular the enteroviruses) and disease development. We review studies that examine whether T1D-specific risk alleles in genes inv...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1192-8

    authors: Blanter M,Sork H,Tuomela S,Flodström-Tullberg M

    更新日期:2019-08-10 00:00:00

  • The forgotten role of glucose effectiveness in the regulation of glucose tolerance.

    abstract::Glucose effectiveness (SG) is the ability of glucose per se to stimulate its own uptake and to suppress its own production under basal/constant insulin concentrations. In an individual, glucose tolerance is a function of insulin secretion, insulin action and SG. Under conditions of declining insulin secretion and acti...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0605-6

    authors: Dube S,Errazuriz-Cruzat I,Basu A,Basu R

    更新日期:2015-06-01 00:00:00

  • From mice to humans.

    abstract::The genomes of many species have now been completely sequenced including human and mouse. Great progress has been made in understanding the complex genetics that underlie diabetes and obesity in human populations. One of the current challenges is the functional identification and characterization of the genes within l...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-012-0323-2

    authors: McMurray F,Moir L,Cox RD

    更新日期:2012-12-01 00:00:00

  • Methods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT).

    abstract:PURPOSE OF REVIEW:The oral glucose tolerance test (OGTT) is used both in clinical practice and research to assess glucose tolerance. In addition, the OGTT is utilized for surrogate measures of insulin sensitivity and the insulin response to enteral glucose and has been widely applied in the evaluation of β-cell dysfunc...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1023-3

    authors: Chen ME,Aguirre RS,Hannon TS

    更新日期:2018-06-16 00:00:00

  • What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?

    abstract:PURPOSE OF REVIEW:We highlight the unique properties of the sodium-glucose cotransporter-2 (SGLT-2 inhibitors) which may lend favorably to their efficient integration in the background of other heart failure (HF) therapies. We also discuss the unique aspects of SGLT-2 inhibitor dosing, lack of titration needs, effects ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01347-3

    authors: Khan MS,Vaduganathan M

    更新日期:2020-10-11 00:00:00

  • Genetics of diabetes complications.

    abstract::A large body of evidence indicates that the risk for developing chronic diabetic complications is under the control of genetic factors. Previous studies using a candidate gene approach have uncovered a number of genetic loci that may shape this risk, such as the VEGF gene for retinopathy, the ELMO1 gene for nephropath...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-010-0147-x

    authors: Doria A

    更新日期:2010-12-01 00:00:00

  • Interventions to Improve Rate of Diabetes Testing Postpartum in Women With Gestational Diabetes Mellitus.

    abstract:PURPOSE OF REVIEW:Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. In the USA, four million women are screened annually for GDM in pregnancy in part to improve pregnancy outcomes but also because diagnosis predicts a high risk of future type 2 diabetes mellitus (T2DM). T...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-017-0835-x

    authors: Hamel MS,Werner EF

    更新日期:2017-02-01 00:00:00

  • Continuous glucose monitoring: current use and future directions.

    abstract::Continuous glucose monitoring (CGM) is an emerging technology that provides a continuous measure of interstitial glucose levels. In addition to providing a more complete pattern of glucose excursions, CGMs utilize real-time alarms for thresholds and predictions of hypo- and hyperglycemia, as well as rate of change ala...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-013-0398-4

    authors: DeSalvo D,Buckingham B

    更新日期:2013-10-01 00:00:00

  • Does disruption of circadian rhythms contribute to beta-cell failure in type 2 diabetes?

    abstract::Type 2 diabetes mellitus (T2DM) is a complex metabolic disease characterized by the loss of beta-cell secretory function and mass. The pathophysiology of beta-cell failure in T2DM involves a complex interaction between genetic susceptibilities and environmental risk factors. One environmental condition that is gaining...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-014-0474-4

    authors: Rakshit K,Thomas AP,Matveyenko AV

    更新日期:2014-04-01 00:00:00

  • Dyslipidemia in type 2 diabetes mellitus.

    abstract::Cardiovascular disease is a significant cause of morbidity and mortality in patients with diabetes mellitus (DM). DM is now recognized as a risk equivalent for coronary heart disease. The lipid profile in patients with type 2 DM is characterized by elevated triglycerides, low levels of high-density lipoprotein cholest...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-007-0036-0

    authors: Gadi R,Samaha FF

    更新日期:2007-06-01 00:00:00

  • Nutrition and nonalcoholic fatty liver disease in children.

    abstract::Nonalcoholic fatty liver disease (NAFLD) is an obesity-associated liver disease found in 3% to 9% of children in the United States. NAFLD represents a spectrum of liver disease and is frequently associated with features of the metabolic syndrome. Nutrition's role in NAFLD is complex. It does not appear that overweight...

    journal_title:Current diabetes reports

    pub_type: 杂志文章

    doi:10.1007/s11892-008-0069-z

    authors: Vos MB,McClain CJ

    更新日期:2008-10-01 00:00:00

  • Thyroid Hormone Signalling Alteration in Diabetic Nephropathy and Cardiomyopathy: a "Switch" to the Foetal Gene Programme.

    abstract:PURPOSE OF THE REVIEW:In this study, we will analyse how diabetes induces the reactivation of organs' developmental programmes and growth, discuss how thyroid hormone (TH) signalling orchestrates these processes, and suggest novel strategies for exploiting TH-mediated reparative and regenerative properties. RECENT FIN...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01344-6

    authors: Mantzouratou P,Lavecchia AM,Novelli R,Xinaris C

    更新日期:2020-09-28 00:00:00

  • The use of bolus insulin and advancing insulin therapy in type 2 diabetes.

    abstract::Attention to meal-related insulin replacement in type 2 diabetes is important as insulin deficiency progresses. The physiology in type 2 and type 1 diabetes differs, and optimal use of basal-bolus therapy in type 2 diabetes requires attention to such issues as the role for oral medications, residual endogenous insulin...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-004-0037-1

    authors: Karl DM

    更新日期:2004-10-01 00:00:00

  • Alginate-based encapsulation of cells: past, present, and future.

    abstract::Replacing dysfunctional endocrine tissues (eg, islets) with healthy, nonautologous material protected against the immune defense of the patient could soon become a reality. Recent advances have resulted in the development of alginate-based microcapsules that meet the demands of biocompatibility, long-term integrity, a...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-007-0051-1

    authors: Zimmermann H,Shirley SG,Zimmermann U

    更新日期:2007-08-01 00:00:00

  • Metabolomic Biomarkers in the Progression to Type 1 Diabetes.

    abstract::Metabolomics is the snapshot of all detectable metabolites and lipids in biological materials and has potential in reflecting genetic and environmental factors contributing to the development of complex diseases, such as type 1 diabetes. The progression to seroconversion to development of type 1 diabetes has been stud...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-016-0820-9

    authors: Overgaard AJ,Kaur S,Pociot F

    更新日期:2016-12-01 00:00:00

  • Possible role of GLP-1 and its agonists in the treatment of type 1 diabetes mellitus.

    abstract::Unfortunately, the only approved medical treatment for type 1 diabetes mellitus (DM) is insulin, despite the fact that tight control cannot be reached without some serious side effects such as hypoglycemia and weight gain. More and more importance is now shifted towards developing new drugs that can reach a better gly...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-012-0291-6

    authors: Issa CM,Azar ST

    更新日期:2012-10-01 00:00:00

  • Retinal vascular changes and diabetic retinopathy.

    abstract::Recent studies support the concept that the retinal vasculature may provide a summary measure of lifetime exposure to the effects of hyperglycemia. Advances in retinal photographic techniques and in image analysis have allowed objective and precise in vivo measurement of retinal vascular changes. In particular, quanti...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-009-0043-4

    authors: Nguyen TT,Wong TY

    更新日期:2009-08-01 00:00:00

  • Genetics of diabetic nephropathy in the Pima Indians.

    abstract::Diabetic nephropathy is the leading cause of renal failure in industrialized countries. There is strong evidence that diabetic nephropathy is influenced by genetic factors. Studies in the Pima Indians as well as in other populations demonstrate that diabetic nephropathy aggregates in families. The hypothesis that the ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-001-0046-2

    authors: Imperatore G,Knowler WC,Nelson RG,Hanson RL

    更新日期:2001-12-01 00:00:00

  • Air Pollution, Oxidative Stress, and Diabetes: a Life Course Epidemiologic Perspective.

    abstract:PURPOSE OF REVIEW:Ambient air pollution is strongly linked to cardiovascular and respiratory diseases. We summarize available published evidence regarding similar associations with diabetes across the life course. RECENT FINDINGS:We performed a life-course survey of the recent literature, including prenatal, gestation...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1181-y

    authors: Lim CC,Thurston GD

    更新日期:2019-07-19 00:00:00

  • MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.

    abstract::Recent estimates suggest that 1 in 12 of the global population suffers from diabetes mellitus. Approximately 40 % of those affected will go on to develop diabetes-related chronic kidney disease or diabetic nephropathy (DN). DN is a major cause of disability and premature death. Existing tests for prognostic purposes a...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-016-0724-8

    authors: Simpson K,Wonnacott A,Fraser DJ,Bowen T

    更新日期:2016-03-01 00:00:00